Catalyst Biosciences catalystbiosciences.com


Public list: BIO 2016 (619) Pharma Startups (4732) Portfolio Company Matchmaking M&A (394) Rare Diseases (230)

Catalyst Biosciences is developing next generation biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery platform rapidly creates and optimizes tailor-made protease drug candidates that cleave a wide variety of disease targets, either by improving existing protease drugs or by creating new protease drugs, known as Alterase therapeutics. Catalyst is focusing its product development efforts on drug candidates for...Show all

Catalyst Biosciences is developing next generation biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery platform rapidly creates and optimizes tailor-made protease...Show all

Company (Merged)

Phone: 650-871-0761

Fax:

260 Littlefield Avenue

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Catalyst Biosciences $111.9M Mar 5, 2015
BIND Therapeutics $198.5M Jul 28, 2016
Bio-Link $0M Nov 29, 2018
See all 19 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Catalyst Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors

Competitors

Company Status Description Investors
See all 19 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Modified factor x polypeptides and uses thereof Apr 03, 2014 Jan 02, 2018 Patent
Modified mt-sp1 proteases that inhibit complement activation May 12, 2014 Oct 24, 2017 Patent
Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes Oct 26, 2015 Feb 28, 2017 Patent
Factor vii polypeptides that are modified and uses thereof Jul 30, 2013 Oct 25, 2016 Patent
Mutant mt-sp1 proteases with altered substrate specificity or activity May 20, 2013 Jun 07, 2016 Patent
See all 18 patents